Association of a COVID-19 diagnosis with adverse events, cohort design, follow-up starting on the day after time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Eligibility assessment, covariate assessment, and follow-up windows relative to time 0 for the cohort design. gan Shelby S. Fisher (22676406)

Pynciau:

Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Characteristics of included individuals for SCRI and cohort analyses. gan Shelby S. Fisher (22676406)

Pynciau:

Analysis set for each outcome and definition. gan Shelby S. Fisher (22676406)

Pynciau:

Eligibility Assessment, Covariate Assessment, Risk Windows, and Reference Windows Relative to Time 0 for the Self-Controlled Risk Interval Design. gan Shelby S. Fisher (22676406)

Pynciau: